Cue Biopharma, Inc.
CUE
$0.768
-$0.0004-0.05%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -52.07% | -40.72% | -48.13% | -38.02% | -36.03% |
| Total Receivables | -44.35% | 89.77% | 62.73% | 614.29% | 2,878.95% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -15.71% | 44.55% | 5.91% | -5.08% | 13.56% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -51.14% | -35.23% | -44.37% | -35.03% | -33.34% |
|
|
|||||
| Total Current Assets | -51.14% | -35.23% | -44.37% | -35.03% | -33.34% |
| Net Property, Plant & Equipment | -31.99% | -43.33% | -39.00% | -35.60% | -33.49% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -25.22% | -9.15% | -9.17% | -4.74% | -12.85% |
| Total Assets | -47.68% | -34.95% | -42.14% | -33.95% | -32.59% |
|
|
|||||
| Total Accounts Payable | -19.37% | 161.05% | 65.79% | 82.19% | 28.19% |
| Total Accrued Expenses | -29.71% | -37.60% | 11.92% | 83.19% | 16.40% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.39% | -6.85% | -4.27% | 13.95% | 39.29% |
| Total Finance Division Other Current Liabilities | -95.98% | -88.43% | -61.68% | -29.00% | -- |
| Total Other Current Liabilities | -95.98% | -88.43% | -61.68% | -29.00% | -- |
| Total Current Liabilities | -19.86% | -2.42% | 0.93% | 30.99% | 47.91% |
|
|
|||||
| Total Current Liabilities | -19.86% | -2.42% | 0.93% | 30.99% | 47.91% |
| Long-Term Debt | -- | -74.26% | -62.63% | -54.16% | -47.70% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -68.28% | -65.60% | -57.33% | -51.64% | -47.46% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -39.90% | -25.85% | -23.76% | -10.32% | -4.52% |
|
|
|||||
| Common Stock & APIC | 6.23% | 8.27% | 6.99% | 7.83% | 6.97% |
| Retained Earnings | -13.50% | -15.50% | -16.97% | -18.96% | -20.26% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -52.81% | -40.55% | -53.00% | -45.40% | -43.54% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -52.81% | -40.55% | -53.00% | -45.40% | -43.54% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -52.81% | -40.55% | -53.00% | -45.40% | -43.54% |
|
|
|||||